Ewing's sarcoma (ES) and primitive neuroectodermal tumor (PNET) are members
of a tumor family consistently associated with chromosomal translocation a
nd functional fusion of the EWS gene to any of several structurally related
transcription factor genes. Similar gene fusion events occur in other mese
nchymal and hematopoietic tumors and are tumor-specific. The resulting nove
l transcription factor-like chimeric proteins are believed to contribute to
tumor biology by aberrant regulation of gene expression altering critical
controls of cell proliferation and differentiation. These tumor-specific mo
lecular rearrangements are useful for primary diagnosis, may provide progno
stic information, and present potential therapeutic targets. The recent adv
ances in our understanding of the molecular biology of ES and PNET represen
t a paradigm for the application of the basic biology of neoplasia to clini
cal management of patients. (C) 2000 by American Society of Clinical Oncolo
gy.